Kenneth Kaushansky, M.D., M.A.C.P. earned his B.S. and M.D. degrees from the University of California, Los Angeles, and completed his Internal Medicine Internship, Residency and Chief Medical Residency, and Fellowship in Hematology at the University of Washington. He joined the faculty at the University of Washington as an Assistant Professor in 1987, was promoted to Associate Professor in 1991 and to Professor in 1995. Following his service as Hematology Section Chief at the University of Washington Medical Center, Dr. Kaushansky was named Helen M. Ranney Professor and Chair of the Department of Medicine at UC San Diego in February 2002.
During his career Dr. Kaushansky has been a successful teacher, clinician and biomedical researcher. His laboratory work has lead to several significant discoveries, for which he received the Dameshek Award from the American Society of Hematology, awarded annually to the scientist who has provided the most seminal insight into the Pathophysiology of hematological disorders, and the Outstanding Investigator Award from the American Society for Medical Research, the most prestigious award of the Society. Dr. Kaushansky is a past-president of the American Society for Clinical Investigation (2004 – 2005) and the Western Society for Clinical Investigation (1998 – 1999) and is the Past President of the American Society of Hematology (ASH). He also served a 5 year term as Editor-in-Chief of the journal Blood (1998-2002) and as a major reviewer for the NIH and many major scientific periodicals. Dr. Kaushansky has been recognized for his scientific and clinical contributions by election as a Master of the American College of Physicians, and to several honor societies and organizations, including the American Society for Clinical Investigation, the Association of American Physicians, the Institute of Medicine of the National Academies of Science and the American Academy of Arts and Sciences.
Dr. Kaushansky is a leading hematologist who has conducted seminal research on the molecular biology of blood cell production. His team has cloned several of the genes important in the growth and differentiation of blood cells, including thrombopoietin, a key regulator of stem cell and platelet production. He is an accomplished clinician, and he has been a champion of the need to train more physician-scientists who can bridge the gap between the laboratory and the clinical arena, translating research discoveries into improved treatments and technologies for the prevention, diagnosis and management of disease.